Physician profile
Diego Rubinowicz
NPI 1669483145
$5,051.94
in general payments reported to CMS, 2019-2025
37 companies · $591 in 2025
The $591 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $182 · 2021: $650 · 2022: $1,135 · 2023: $1,179 · 2024: $984 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,726 · Entertainment: $17.99 · Debt Forgiveness: $9.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,726.07 |
| Entertainment | $17.99 |
| Debt Forgiveness | $9.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $621.42 | 2022-2025 | |
| Astellas Pharma US INC | $478.10 | 2021-2025 | Xtandi |
| Antares Pharma, INC. | $428.58 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Olympus America INC. | $328.95 | 2019-2025 | Itind System, Soltive, Oes Cystonephrofiberscope |
| Boston Scientific Corporation | $299.55 | 2019-2023 | Spaceoar Vue System - 10ml |
| Endo Pharmaceuticals INC. | $293.36 | 2019-2024 | Xiaflex, Aveed, Edex |
| Janssen Biotech, INC. | $268.79 | 2019-2025 | Erleada |
| Pfizer INC. | $237.34 | 2019-2024 | |
| Laborie Medical Technologies Corp. | $208.36 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Myovant Sciences INC. | $193.33 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $172.12 | 2022-2023 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $161.59 | 2023-2025 | Orgovyx |
| Myriad Genetic Laboratories, INC. | $154.35 | 2024 | Prolaris |
| Edap Technomed INC | $149.45 | 2022 | |
| Tolmar, INC. | $138.48 | 2023-2025 | Eligard, Jatenzo |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $99.26 | 2022-2023 | Botox, Lupron Depot |
| Becton, Dickinson and Company | $97.31 | 2023 | Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Endo USA, INC. | $76.09 | 2024-2025 | Xiaflex, Aveed |
| Medtronic, INC. | $65.20 | 2022-2024 | Interstim |
| Blue Earth Diagnostics | $62.11 | 2021-2024 | |
| Halozyme INC | $59.81 | 2023 | |
| Accord Healthcare, INC. | $59.43 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.94 | 2022-2025 | |
| Allergan, INC. | $44.99 | 2021-2022 | |
| Rochester Medical Corporation | $44.11 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $36.78 | 2023 | Seglentis |
| Coloplast Corp | $31.24 | 2023 | Speedicath, Torosa |
| Immunitybio, INC. | $27.82 | 2025 | |
| Urovant Sciences INC | $22.96 | 2022 | |
| Ferring Pharmaceuticals INC. | $22.29 | 2024 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $22.00 | 2023 | |
| Calyxo, INC. | $19.18 | 2025 | Cvac Aspiration System |
| Provepharm INC. | $17.99 | 2024 | Bludigo |
| Philips North America LLC | $16.84 | 2025 | Oncology Solution |
| Profound Medical Corp. | $15.27 | 2022 | |
| Photocure INC | $14.85 | 2024 | Cysview |
| Dendreon Pharmaceuticals LLC | $13.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diego Rubinowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.